IRVINE, CA -- (MARKET WIRE) -- January 09, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has finalized a Memorandum of Understanding with CMI Medical Ltd., of Seoul, South Korea, to be the company’s exclusive distributor for the AquaSonix Therapy and enSonix@home medical devices. CMI Medical will be commencing the registration process with South Korea’s KFDA, the Korean equivalent of the FDA [US Food and Drug Administration], and plans to take the initial delivery of product in the first half of 2007. The first year of the agreement is estimated to be worth in excess of $3.5 million to HealthSonix once optional accessories for the device are included. A 30% annual sales escalation clause forms part of the agreement and CMI has to generate sales in excess of $4.5 million in 2008 to maintain exclusivity for the Korean market.
